Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 6,475 | 8,149 | 10,204 | 9,156 | 9,311 |
| Operating Income | -6,475 | -8,149 | -10,204 | -9,156 | -9,311 |
| Other Income | 2,160 | 5,091 | 7,732 | 667 | 3,547 |
| Pre-tax Income | -4,315 | -3,058 | -2,472 | -8,489 | -5,764 |
| Net Income Continuous | -4,315 | -3,058 | -2,472 | -8,489 | -5,764 |
| Minority Interests | -60 | -212 | -97 | -136 | -82 |
| Net Income | $-4,255 | $-2,846 | $-2,375 | $-8,353 | $-5,682 |
| EPS Basic Total Ops | -262.24 | -174.83 | -174.83 | -786.71 | -524.48 |
| EPS Basic Continuous Ops | -306.64 | -227.60 | -146.28 | -811.49 | -553.58 |
| EPS Diluted Total Ops | -262.24 | -174.83 | 174.83 | -786.71 | -874.13 |
| EPS Diluted Continuous Ops | -306.64 | -227.60 | -163.46 | -811.49 | -536.40 |
| EBITDA(a) | $-6,416 | $-8,092 | $-10,158 | $-9,102 | $-9,291 |